Detailed answers about OXFORD DRUG DESIGN LIMITED, including incorporation, status, business activity, and accounts information.
When was OXFORD DRUG DESIGN LIMITED founded?
OXFORD DRUG DESIGN LIMITED was officially incorporated on 17 October 2001 and is registered under company number 04305857. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is OXFORD DRUG DESIGN LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of OXFORD DRUG DESIGN LIMITED?
OXFORD DRUG DESIGN LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does OXFORD DRUG DESIGN LIMITED do?
OXFORD DRUG DESIGN LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is OXFORD DRUG DESIGN LIMITED's registered address?
The registered office address of OXFORD DRUG DESIGN LIMITED is OXFORD CENTRE FOR INNOVATION BLUE BOAR COURT, 9 ALFRED STREET, OXFORD, ENGLAND, OX1 4EH. This is the official address filed with Companies House for legal and statutory correspondence.
Is OXFORD DRUG DESIGN LIMITED financially stable?
The most recent accounts for OXFORD DRUG DESIGN LIMITED were made up to 31 December 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 September 2026.
Has OXFORD DRUG DESIGN LIMITED changed its name?
Yes, OXFORD DRUG DESIGN LIMITED has had 1 previous name: INHIBOX LIMITED (changed 15 May 2017).